Enron Pharmaceuticals Private Limited
About Enron Pharmaceuticals Private Limited
Data last updated:
Enron Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 12 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2015PTC279954.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohan Bhandari and Sukumar Jana.
Its last annual general meeting (AGM) was held on 14 July 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at H – 16/1939 G/F Sangam Vihar Near Homli School, New Delhi, Delhi, India – 110062.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Enron Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH – 16/1939 G/F Sangam Vihar Near Homli School, New Delhi, Delhi, India – 110062
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Enron Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Enron Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Enron Pharmaceuticals Private Limited
FY 2017 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Enron Pharmaceuticals Private Limited, buy the company report.
Board of directors of Enron Pharmaceuticals Private Limited
Enron Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohan Bhandari | Director | 12 May 2015 | 11 Years 5 Months | Current |
| Sukumar Jana | Director | 12 May 2015 | 11 Years 5 Months | Current |
Auditor
Enron Pharmaceuticals Private Limited is audited by AKNBM & Company for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AKNBM & Company | FY 2017 | 028887N |
Shareholding
The shareholding of Enron Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Enron Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Enron Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Enron Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Enron Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Enron Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Mohan Bhandari was appointed as Director on 12 May 2015.
Frequently asked questions
Enron Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 12 May 2015 (11+ years old) and is registered under CIN U85100DL2015PTC279954.
Enron Pharmaceuticals has 2 current directors:
- Mohan Bhandari - Director
- Sukumar Jana - Director
The latest financial statements of Enron Pharmaceuticals on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 14 July 2017. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Enron Pharmaceuticals is U85100DL2015PTC279954. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Enron Pharmaceuticals was incorporated on 12 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Mohan Bhandari was appointed as Director on 12 May 2015. Sukumar Jana was appointed as Director on 12 May 2015.
The registered office of Enron Pharmaceuticals is at H – 161939 GF Sangam Vihar Near Homli School, New Delhi, Delhi, India – 110062.
Enron Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Enron Pharmaceuticals is active non-compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Enron Pharmaceuticals can be reached at its registered office: H – 161939 GF Sangam Vihar Near Homli School, New Delhi, Delhi, India – 110062.